Sylebra Capital LLC raised its stake in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 2.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,834,750 shares of the company's stock after buying an additional 37,883 shares during the quarter. Xometry accounts for about 2.9% of Sylebra Capital LLC's portfolio, making the stock its 9th largest position. Sylebra Capital LLC owned approximately 3.70% of Xometry worth $78,270,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XMTR. 49 Wealth Management LLC acquired a new stake in Xometry in the fourth quarter worth $319,000. State of Wyoming increased its position in shares of Xometry by 8.2% in the 4th quarter. State of Wyoming now owns 8,876 shares of the company's stock valued at $379,000 after buying an additional 676 shares in the last quarter. Polar Capital Holdings Plc bought a new stake in shares of Xometry in the 4th quarter valued at $14,070,000. ProShare Advisors LLC acquired a new stake in Xometry during the 4th quarter worth $511,000. Finally, Nuveen Asset Management LLC lifted its holdings in Xometry by 1.7% during the fourth quarter. Nuveen Asset Management LLC now owns 525,867 shares of the company's stock worth $22,433,000 after acquiring an additional 8,589 shares in the last quarter. Institutional investors own 97.31% of the company's stock.
Insider Transactions at Xometry
In related news, CFO James Miln sold 1,346 shares of the company's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $25.13, for a total transaction of $33,824.98. Following the sale, the chief financial officer now owns 144,713 shares in the company, valued at approximately $3,636,637.69. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Emily Rollins sold 10,041 shares of the firm's stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $30.70, for a total value of $308,258.70. Following the completion of the transaction, the director now owns 11,105 shares of the company's stock, valued at approximately $340,923.50. This represents a 47.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,496 shares of company stock valued at $1,288,659 over the last 90 days. 9.66% of the stock is owned by corporate insiders.
Xometry Stock Up 0.6%
NASDAQ:XMTR traded up $0.20 during trading hours on Friday, reaching $33.07. 607,163 shares of the stock were exchanged, compared to its average volume of 601,274. The stock has a market cap of $1.66 billion, a PE ratio of -31.49 and a beta of 0.71. Xometry, Inc. has a twelve month low of $11.08 and a twelve month high of $45.33. The firm has a 50 day moving average of $26.93 and a 200 day moving average of $31.06. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.59 and a quick ratio of 4.55.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on XMTR shares. Citigroup lowered their price target on Xometry from $46.00 to $39.00 and set a "buy" rating for the company in a report on Thursday, February 27th. Royal Bank of Canada increased their target price on Xometry from $32.00 to $36.00 and gave the stock a "sector perform" rating in a research note on Wednesday, May 7th. JPMorgan Chase & Co. dropped their target price on shares of Xometry from $45.00 to $30.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. JMP Securities reaffirmed a "market outperform" rating and issued a $42.00 price target on shares of Xometry in a research note on Monday, February 10th. Finally, UBS Group increased their price objective on shares of Xometry from $33.00 to $35.00 and gave the stock a "neutral" rating in a research report on Wednesday, May 7th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Xometry presently has an average rating of "Moderate Buy" and a consensus target price of $34.89.
Check Out Our Latest Analysis on Xometry
Xometry Profile
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Read More

Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.